Henchcliffe, Claire http://orcid.org/0000-0002-0899-3030
Sarva, Harini
Article History
First Online: 29 May 2020
Compliance with Ethical Standards
:
: No funding was received by either author for the preparation of this manuscript.
: Dr Henchcliffe has received honoraria for consulting for the California Institute of Regenerative Medicine (CIRM) Grant Working Group and research funding as an investigator in a research consortium from New York State Stem Cell Science (NYSTEM). Unrelated to this manuscript she has the following disclosures: honorarium for lecture from the Houston Methodist Neurological Institute; honoraria for ad hoc advisory board participation from US WorldMeds, Adamas Pharmaceuticals, Mitsubishi Tanabe Pharma Inc., and Prevail Therapeutics; and funding from the Michael J. Fox Foundation, National Institute of Health, Insightec, and Prevail Therapeutics. Dr H Sarva has received funding from the Michael J Fox Foundation, and clinical trial support from Biogen, Insightec and Lundbeck Pharmaceuticals. She has received honoraria for participation in advisory boards for Merz and Amneal pharmaceuticals, and for serving as an independent video rater for Neurocrine Neurosciences.